Premature atherosclerosis is the major cause of morbidity and mortality in both types 1 and 2 diabetes. The overall objective of this Program Project is to better understand biochemical and molecular mechanisms involved in the pathogenesis of diabetic macrovascular disease. The program project is comprised of 4 inter-related projects and 3 cores. Project 1 will study the the role of an inflammatory molecule, serum amyloid A (SAA) in mediating the interaction of atherogenic lipoproteins with the vascular wall, thereby enhancing atherosclerosis. It will investigate how SAA alters the interaction of lipoproteins with extracellular vascular matrix molecules and alters cellular lipid metabolism and endothelial activation providing insight into the link between inflammation and atherosclerosis in diabetes. Project 2 is aimed at understanding the role of fatty acyl-CoA synthesis in the initiation of atherosclerosis in diabetes. Acyl-CoA synthesis is increased in diabetes. The effect of modulation of acyl-CoA synthesis in endothelial cells and macrophages on lesion initiation and inflammation is the focus of this project. Project 3 will study the role of diabetes on the regulation of reverse cholesterol transport, a process that plays a critical role in atherogenesis. The effect of diabetes on transporters that play critical roles in removing excess lipids from cells will be studied in this project. Project 4 will study biochemical pathways involved in glycation and glycoxidation reactions that play a role in damaging HDL, thereby accelerating atherosclerosis in diabetes. This project will also assess how the diabetic milieu alters HDL's protein composition and its anti-inflammatory properties. Diabetes-mediated alterations in HDL composition and function could impair HDL's atheroprotective functions and accelerate atherosclerosis in diabetes. These projects will be supported by an administrative and 2 scientific cores: The Mouse and Tisssue Core will provide the projects with mice and histochemical and immunohistochemical evaluation of tissues from several mouse models of diabetes. The Mass Spectrometry Core will provide sophisticated biochemical support for the in vitro and in vivo studies proposed in all the projects. The increased understanding of the pathogenesis of the premature vascular disease in diabetes that will be derived has important therapeutic implications for the prevention and treatment of macrovascular disease in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL092969-51
Application #
8105150
Study Section
Special Emphasis Panel (ZHL1-PPG-J (M2))
Program Officer
Ershow, Abby
Project Start
1997-03-01
Project End
2013-05-31
Budget Start
2011-06-01
Budget End
2012-05-31
Support Year
51
Fiscal Year
2011
Total Cost
$2,226,221
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ronsein, Graziella E; Heinecke, Jay W (2017) Time to ditch HDL-C as a measure of HDL function? Curr Opin Lipidol 28:414-418
Heinecke, Jay W; Bornfeldt, Karin E (2017) A Long Road Ahead for Discovering New HDL Metrics That Reflect Cardiovascular Disease Risk. J Am Coll Cardiol 70:179-181
Ronsein, Graziella E; Vaisar, Tomáš (2017) Inflammation, remodeling, and other factors affecting HDL cholesterol efflux. Curr Opin Lipidol 28:52-59
Wall, Valerie Z; Barnhart, Shelley; Kramer, Farah et al. (2017) Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (?C20)-acyl chains in macrophages. J Lipid Res 58:1174-1185
Pamir, Nathalie; Hutchins, Patrick M; Ronsein, Graziella E et al. (2017) Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight 2:
Den Hartigh, Laura J; Omer, Mohamed; Goodspeed, Leela et al. (2017) Adipocyte-Specific Deficiency of NADPH Oxidase 4 Delays the Onset of Insulin Resistance and Attenuates Adipose Tissue Inflammation in Obesity. Arterioscler Thromb Vasc Biol 37:466-475
Ruparelia, Neil; Chai, Joshua T; Fisher, Edward A et al. (2017) Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol 14:133-144
Kraakman, Michael J; Lee, Man Ks; Al-Sharea, Annas et al. (2017) Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest 127:2133-2147
Kothari, Vishal; Bornfeldt, Karin E (2017) Liver Kinase B1 Links Macrophage Metabolism Sensing and Atherosclerosis. Circ Res 121:1024-1026
Pamir, Nathalie; Hutchins, Patrick; Ronsein, Graziella et al. (2016) Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res 57:246-57

Showing the most recent 10 out of 113 publications